EURAND

eurand-logo

Eurand N.V. (Eurand) is a holding company. The Company is a specialty pharmaceutical company that develops, manufactures and commercializes pharmaceutical and biopharmaceutical products. The Company is commercializing a portfolio of products for cystic fibrosis (CF) and gastrointestinal (GI) patients in the United States. As of December 31, 2009, it had two late-stage product candidates, EUR-1073 (beclomethasone) and EUR-1025 (ondansetron) in development in its own portfolio, as well as a number of other products in development with collaboration partners, including EUR-1000, which is partnered with GlaxoSmithKline (GSK). It has manufacturing and research facilities in the United States, Italy and France.

#People #Website #More

EURAND

Industry:
Biotechnology

Founded:
1984-01-01

Address:
Amsterdam, Noord-Holland, The Netherlands

Country:
The Netherlands

Website Url:
http://www.eurand.com

Status:
Closed

Contact:
(800) 678-1605

Technology used in webpage:
Microsoft Exchange Online ATT DNS


Current Employees Featured

theresa-stevens_image

Theresa Stevens
Theresa Stevens Senior Vice President and Chief Corporate Development Officer @ Eurand
Senior Vice President and Chief Corporate Development Officer

gearoid-m-faherty_image

Gearoid M. Faherty
Gearoid M. Faherty Founder, Chairman, and CEO @ Eurand
Founder, Chairman, and CEO

rick-maroun_image

Rick Maroun
Rick Maroun Senior Vice President, General Counsel & Corporate Secretary @ Eurand
Senior Vice President, General Counsel & Corporate Secretary

Founder


gearoid-m-faherty_image

Gearoid M. Faherty

Stock Details


Company's stock symbol is NASDAQ:EURX

Official Site Inspections

http://www.eurand.com

Unable to get host informations!!!

Loading ...

More informations about "Eurand"

Eurand - Crunchbase Company Profile & Funding

Eurand is a specialty pharmaceutical company offering a range of products to โ€ฆSee details»

Eurand Company Profile | Management and Employees List

Eurand Profile and History Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products โ€ฆSee details»

Eurand 2025 Company Profile: Valuation, Investors, โ€ฆ

Information on acquisition, funding, investors, and executives for Eurand. Use the PitchBook Platform to explore the full profile.See details»

Eurand - 2025 Company Profile - Tracxn

Jun 10, 2025 Eurand - R&D company focused on manufacturing cystic fibrosis drugs for multiple therapeutic areas. Acquired by Allergan.See details»

Eurand S.p.A - Products, Competitors, Financials, Employees ...

About Eurand S.p.A The company are a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products โ€ฆSee details»

Eurand - Overview, News & Similar companies | ZoomInfo.com

View Eurand (www.eurand.com) location in Pennsylvania, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

Eurand N.V.: Contact Details and Business Profile - RocketReach

Eurand N.V. is a Healthcare, Pharmaceuticals, and Drug Manufacturing & Research company located in Vandalia, Ohio with $153.60 Million in revenue and 620 employees. Find top โ€ฆSee details»

Eurand Pharmaceuticals, Inc. Company Profile - Dun & Bradstreet

Home / Business Directory / Manufacturing / Chemical Manufacturing / Pharmaceutical And Medicine Manufacturing / United States / Pennsylvania / Yardley / Eurand Pharmaceuticals, Inc.See details»

Eurand Pharmaceuticals Inc - Company Profile and News

Company profile page for Eurand Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»

Eurand, Inc.:Company Profile & Technical Research,Competitor โ€ฆ

Oct 9, 2022 Eurand Inc is a company that provides Biopharmaceutical, Botanical drug, Herb and more. Eurand Inc is headquartered in US OH. Eurand Inc was founded in 1969. Eurand Inc โ€ฆSee details»

Eurand (Milan) - [LSE] Life-Sciences-Europe.com - The European โ€ฆ

Https://www.eurand.com Eurand is a specialty pharmaceutical company with research and manufacturing facilities in Milan and Trieste, Italy; Dayton, Ohio, USA; and Paris, France. *See details»

Eurand - World Pharmaceutical Frontiers

A wide range of capabilities and a unique business model has drawn talent to a speciality pharmaceutical company. Robert Becker, PhD, joined Eurand as chief research officer, a โ€ฆSee details»

Company EURAND N.V. - MarketScreener.com

EURAND N.V.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: | NasdaqSee details»

Eurand agrees to around $583 million acquisition by Axcan

Dec 2, 2010 Dutch specialty pharmaceutical company, Eurand NV (Nasdaq: EURX) has agreed to be acquired by privately-held US firm Axcan Holdings, which is focused on the treatment of โ€ฆSee details»

What is Eurand? Company Culture, Mission, Values | Glassdoor

See what employees say it's like to work at Eurand. Salaries, reviews, and more - all posted by employees working at Eurand.See details»

Eurand Pharmaceuticals Holdings BV - Company Profile and News

Company profile page for Eurand Pharmaceuticals Holdings BV including stock price, company news, executives, board members, and contact informationSee details»

Eurand - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Eurand is a specialty pharmaceutical company offering a range of products to cystic fibrosis and gastrointestinal patients in the U.S.See details»

Eurand SpA - Company Profile and News - Bloomberg Markets

Company profile page for Eurand SpA including stock price, company news, executives, board members, and contact informationSee details»

DNS: How to Improve Your Companyโ€™s Infrastructure - EBRAND

May 2, 2025 Want to secure your organization's online presence, while boosting performance and growth? Check out the latest DNS tips.See details»

Rogue Websites: The Top Five Most Dangerous Website Scams

Jul 17, 2025 With fake login pages and phishing domains getting more convincing than ever, it's time for businesses to fight back against rogue websites.See details»